Back
Viridian Therapeutics Quote, Financials, Valuation and Earnings
The dark truth about AI
Click here to learn more...
Sell
10
VRDN
Viridian Therapeutics
Last Price:
17.86
Seasonality Move:
4.07%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Viridian Therapeutics Price Quote
$17.86
+0.01 (+-0.72%)
(Updated: December 14, 2024 at 5:57 AM ET)
Viridian Therapeutics Key Stats
Sell
10
Viridian Therapeutics (VRDN)
is a Sell
Day range:
$17.25 - $17.99
52-week range:
$11.40 - $27.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3,592.38
P/B ratio:
2.75%
Volume:
1.5M
Avg. volume:
1.2M
1-year change:
-7.18%
Market cap:
$1.4B
Revenue:
$314K
EPS:
$-4.31
How Much Does Viridian Therapeutics Make?
-
How Much Are Viridian Therapeutics's Sales Annually?
VRDN Revenues are $314K -
How Much Profit Does Viridian Therapeutics's Make A Year?
VRDN net income is -$237.7M
Is Viridian Therapeutics Growing As A Company?
-
What Is Viridian Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.19% -
What Is Viridian Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Viridian Therapeutics Stock Price Performance
-
Did Viridian Therapeutics Stock Go Up Last Month?
Viridian Therapeutics share price went down by -20.6% last month -
Did VRDN's Share Price Rise Over The Last Year?
VRDN share price fell by -7.18% over the past 1 year
What Is Viridian Therapeutics 52-Week High & Low?
-
What Is Viridian Therapeutics’s 52-Week High Share Price?
Viridian Therapeutics has traded as high as $27.20 over the past 52 weeks -
What Is Viridian Therapeutics’s 52-Week Low Share Price?
Viridian Therapeutics has traded as low as $11.40 over the past 52 weeks
Viridian Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Viridian Therapeutics?
-
How Much Debt Does Viridian Therapeutics Have?
Total long term debt quarterly is $20.5M -
How Much Cash Does Viridian Therapeutics Have?
Cash and short term investments quarterly total is $753.2M -
What Is Viridian Therapeutics’s Book Value Per Share?
Book value per share is 6.55
Is Viridian Therapeutics Cash Flow Positive?
-
What Is VRDN Cash Flow From Operations?
Cash flow from operations (TTM) is -$197M -
What Is Viridian Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $621.2M -
What Is Viridian Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$335.4M
Viridian Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
VRDN return on invested capital is -48.57% -
What Is Viridian Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -45.79% -
What Is VRDN Return On Equity?
ROE is a measure of profitability and is -50.51%
Viridian Therapeutics Earnings Date & Stock Price
-
What Is Viridian Therapeutics's Stock Price Today?
A single share of VRDN can be purchased today for 17.85 -
What Is Viridian Therapeutics’s Stock Symbol?
Viridian Therapeutics trades on the nasdaq under the ticker symbol: VRDN -
When Is Viridian Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Viridian Therapeutics is scheduled on February 27, 2025 -
When Is VRDN's next ex-dividend date?
Viridian Therapeutics's next ex-dividend date is December 14, 2024 -
How To Buy Viridian Therapeutics Stock?
You can buy Viridian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Viridian Therapeutics Competitors
-
Who Are Viridian Therapeutics's Competitors?
Below is a list of companies who compete with Viridian Therapeutics or are related in some way:
Viridian Therapeutics Dividend Yield
-
What Is VRDN Dividend Yield?
Viridian Therapeutics’s dividend yield currently is 0% -
What Is Viridian Therapeutics’s Payout Ratio?
Viridian Therapeutics’s payout ratio is 0% -
When Did Viridian Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 14, 2024 -
What Is Viridian Therapeutics’s Dividend Per Share?
Viridian Therapeutics pays a dividend of $0.00 per share
Viridian Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -9.52% |
| Revenue: | 19.44% | 73.46% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 40.63 |
| Upside from Last Price: | 127.59% |